Related Experiment Video
Updated: Jul 3, 2026

Microfluidic Approach to Resolve Simultaneous and Sequential Cytokine Secretion of Individual Polyfunctional Cells
Published on: March 8, 2024
The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ
1Department of Emergency Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Tsinghua University, Beijing 100730, PR China. houli_wang@yahoo.com
Abstract:
Multiple organ dysfunction syndrome (MODS) is a major cause of morbidity and mortality in intensive care units. It is being encountered frequently in critically ill patients owing to advancements in organ-specific supportive technologies to survive the acute phase of severe sepsis and shock. It is now believed that MODS is the result of an inappropriate generalized inflammatory response of the host to a variety of acute insults. The pathologic mechanisms of MODS were reviewed, and factors determining the sequence and severity of organ dysfunction were discussed in depth. In the early phase of MODS, circulating cytokines cause universal endothelium injury in organs. In the later phase of MODS, overexpression of inflammatory mediators in the interstitial space of various organs is considered a main mechanism of parenchyma injury. The difference in constitutive expression and the upregulation of adhesion molecules in vascular beds and the density and potency of intrinsic inflammatory cells in different organs are the key factors determining the sequence and severity of organ dysfunction. By activating the intrinsic inflammatory cell in a distant organ, organ dysfunctions are linked in a positive feedback loop through circulating inflammatory mediators. Antagonists targeted at adhesion molecules may alleviate the severity of endothelial damage. And nonsteroidial anti-inflammatory drugs or steroids administered judiciously in the early phase of MODS may retard the progress of multiple organ failure.
Insights
Multiple organ dysfunction syndrome (MODS) stems from an inappropriate inflammatory response to acute injury. Understanding inflammatory mediators and adhesion molecules is key to mitigating organ failure in critically ill patients.
Area of Science:
- Critical Care Medicine
- Pathophysiology
- Immunology
Background:
- Multiple organ dysfunction syndrome (MODS) is a leading cause of death in intensive care units.
- Advancements in supportive care increase patient survival through acute phases of sepsis and shock, leading to more frequent encounters with MODS.
- MODS is increasingly recognized as a systemic inflammatory response to diverse acute insults.
Purpose of the Study:
- To review the pathological mechanisms underlying MODS.
- To discuss factors influencing the sequence and severity of organ dysfunction in MODS.
- To explore potential therapeutic targets for mitigating MODS progression.
Main Methods:
- Review of existing literature on MODS pathophysiology.
- Analysis of the roles of cytokines, inflammatory mediators, and adhesion molecules.
- Discussion of organ-specific factors contributing to differential dysfunction.
Main Results:
- Early MODS involves circulating cytokines causing widespread endothelial injury.
- Later MODS is characterized by interstitial inflammatory mediator overexpression, leading to parenchymal injury.
- Organ-specific differences in adhesion molecule expression and inflammatory cell activity dictate the pattern and severity of dysfunction.
- A positive feedback loop links organ failures via circulating mediators activating intrinsic inflammatory cells.
Conclusions:
- Adhesion molecule antagonists may reduce endothelial damage in MODS.
- Judicious use of anti-inflammatory drugs or steroids early in MODS may slow the progression to multiple organ failure.
- Understanding the inflammatory cascade and organ-specific vulnerabilities is crucial for managing MODS.
Related Concept Videos
Acute Inflammation III: Local and Systemic Effects
Acute Pancreatitis II: Pathophysiology
Acute Kidney Injury II: Pathophysiology
Myocarditis I: Introduction
Cytotoxic Edema: Pathophysiology
Chronic Inflammation: Introduction

